Monday, April 29, 2019

FDA grants orphan drug status to AUTO3 for ALL

The FDA has granted orphan drug status to AUTO3, a cell-based immunotherapy for the treatment of acute lymphoblastic leukemia (ALL).
AUTO 3 (Autolus Therapeutics) is a programmed T-cell therapy containing two independent chimeric antigen receptors targeting CD19 and CD22 that are independently optimized for single-target activity.
“By simultaneously targeting two B cell antigens, AUTO3 is designed to minimize relapse due to single antigen loss in patients with B cell malignancies,” according to a press release from the manufacturer.
“We believe that AUTO3 has the potential to be a best-in-class therapy in pediatric ALL by addressing antigen escape, a common cause of relapse in these patients,” Christian Itin, PhD, CEO of Autolus, said in a press release. “AUTO3 may also provide an improved safety profile over currently marketed CAR T therapies with low levels of severe (cytokine release syndrome) and neurotoxicity observed in clinical studies.”
AUTO3 is currently being tested in pediatric patients with ALL as part of the AMELIA clinical trial and in patients with diffuse large B cell lymphoma in the ALEXANDER clinical trial.
Data from the American Cancer Society suggest there will be 5,930 new cases of ALL and approximately 1,500 deaths in 2019. Sixty percent of cases will be in patients aged younger than 20 years.
The FDA Office of Orphan Products Development grants orphan drug designation to novel drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the United States. The designation allows manufacturers to qualify for various incentives, including tax credits for qualified clinical trials and — upon regulatory approval — 7 years of market exclusivity.

Get to know more about hematology/ oncology by joining us at Rome, Italy, this July, PS: World Hematology 2019  

2 comments:

  1. Ask specialists and the staff individuals what sort of treatment plans they offer, since you would prefer not to feel like there is just a "one size fits all" treatment plan. Additionally, a few people experience the ill effects of a psychological issue notwithstanding an enslavement. Ask the dependence place staff, on the off chance that they offer double analysis treatment, which treats the individual experiencing fixation just as coinciding state of mind. To put it plainly, the liquor treatment office should work to treat all reasons for compulsion so as to forestall any backslide later on.
    inspirational sayings for recovering addicts
    inspirational quotes for someone in rehab

    ReplyDelete
  2. Outpatients, on the other hand, are revealed reliably to the equal perilous condition where their reliance began, with all of its allurements and updates. To be productive, the outpatient drug rehab program would not simply bring to the table all the organizations of inpatient care, it would similarly need to effectively deal with the biological dangers the recovering rascal faces every day. It's generously more difficult to keep up your assurance under those conditions. Believe it or not, one examination of inpatient versus outpatient alcohol rehab found that, with everything else being equal, outpatient clients were on different occasions bound to be early treatment dissatisfactions than inpatient clients. Toward the day's end, four overlap the quantity of addicts walk around their obsession is dealt with.
    drug rehab florida

    ReplyDelete